BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19590442)

  • 1. Abdominal pain in a patient with ankylosing spondylitis under treatment with infliximab.
    Cooper J; Flückiger B; Traichl B; Diener PA; Otto P; von Kempis J
    J Clin Rheumatol; 2009 Aug; 15(5):244-6. PubMed ID: 19590442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal tuberculosis mimicking Crohn disease in infliximab-treated rheumatoid arthritis.
    Bruzzese V; Lorenzetti R; Zullo A; Campo SM; Hassan C
    J Clin Rheumatol; 2012 Sep; 18(6):324. PubMed ID: 22955489
    [No Abstract]   [Full Text] [Related]  

  • 3. Tuberculous peritonitis in a patient with rheumatoid arthritis.
    Kagohashi K; Ohara G; Kurishima K; Satoh H
    J Clin Rheumatol; 2014 Jan; 20(1):57-8. PubMed ID: 24356485
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents.
    Gao X; Wendling D; Botteman MF; Carter JA; Rao S; Cifaldi M
    J Med Econ; 2012; 15(6):1054-63. PubMed ID: 22563743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents.
    Braun J; Baraliakos X; Listing J; Davis J; van der Heijde D; Haibel H; Rudwaleit M; Sieper J
    Arthritis Rheum; 2007 May; 57(4):639-47. PubMed ID: 17471540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of ankylosing spondylitis and Crohn's disease successfully treated with infliximab.
    Rebelo A; Leite S; Cotter J
    BioDrugs; 2010 Dec; 24 Suppl 1():37-9. PubMed ID: 21175236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculous peritonitis.
    Finlay DG; Szauter K; Raju GS; Snyder N
    Am J Gastroenterol; 2005 Jul; 100(7):1624-5. PubMed ID: 15984997
    [No Abstract]   [Full Text] [Related]  

  • 8. Do Anti-TNF Agents Increase the Risk of Inflammatory Bowel Disease Evolution in Patients with Ankylosing Spondylitis? Real Life Data.
    Üsküdar Cansu D; Üsküdar Teke H; Temel T; Ertürk A; Kahraman O; Korkmaz C
    J Natl Med Assoc; 2019 Jun; 111(3):262-269. PubMed ID: 30389147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [18-year-old anemic patient with chronic abdominal pain, weight loss and amenorrhea].
    Heigl F; König G; Hacker H; Erdmann E; Wiebecke B
    Internist (Berl); 1990 Jun; 31(6):429-32. PubMed ID: 2376487
    [No Abstract]   [Full Text] [Related]  

  • 10. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitiligo improvement in a patient with ankylosing spondylitis treated with infliximab.
    Simón JA; Burgos-Vargas R
    Dermatology; 2008; 216(3):234-5. PubMed ID: 18182816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response.
    Braun J; Baraliakos X; Listing J; Fritz C; Alten R; Burmester G; Krause A; Schewe S; Schneider M; Sörensen H; Zeidler H; Sieper J
    Ann Rheum Dis; 2008 Mar; 67(3):340-5. PubMed ID: 17967831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapsing cutaneous leishmaniasis in a patient with ankylosing spondylitis treated with infliximab.
    Mueller MC; Fleischmann E; Grunke M; Schewe S; Bogner JR; Löscher T
    Am J Trop Med Hyg; 2009 Jul; 81(1):52-4. PubMed ID: 19556566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple paradoxical adverse events in a patient affected with ankylosing spondylitis treated with TNF blockers.
    Lo Nigro A; Ramonda R; Alaibac M; Modesti V; Punzi L
    Eur J Dermatol; 2011; 21(2):263-4. PubMed ID: 21411412
    [No Abstract]   [Full Text] [Related]  

  • 15. Localized Cutaneous Leishmaniasis due to Leishmania infantum in a Patient Treated with Infliximab.
    Hakimi S; Rivière S; Del Giudice P; Dereure J; Le Quellec A
    Dermatology; 2010; 220(1):63-5. PubMed ID: 19907139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatitis herpetiformis in a patient receiving infliximab for ankylosing spondylitis.
    Marakli SS; Uzun S; Ozbek S; Tuncer I
    Eur J Dermatol; 2008; 18(1):88-9. PubMed ID: 18086603
    [No Abstract]   [Full Text] [Related]  

  • 17. Fertility and reproduction in male patients with ankylosing spondylitis treated with infliximab.
    Paschou S; Voulgari PV; Vrabie IG; Saougou IG; Drosos AA
    J Rheumatol; 2009 Feb; 36(2):351-4. PubMed ID: 19040305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of leprosy in a patient with ankylosing spondylitis during the infliximab treatment: reactivation of a latent infection?
    Vilela Lopes R; Barros Ohashi C; Helena Cavaleiro L; de Britto Pereira Cruz R; da Veiga RR; Fernando Ribeiro Miranda M; Toshimitsu Yoshikawa G
    Clin Rheumatol; 2009 May; 28(5):615-7. PubMed ID: 19259757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-TNF alfa therapy in ankylosing spondylitis].
    Cravo AR; Tavares V; Da Silva JC
    Acta Med Port; 2006; 19(2):141-50. PubMed ID: 17187716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptosporidiosis in a patient with ankylosing spondylitis treated with adalimumab.
    Chiuchetta FA
    Rev Bras Reumatol; 2010; 50(3):328-32. PubMed ID: 21125168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.